Targeted urothelial regeneration via organoid-based therapy in bladder injury

Yuxin L1, Liao P1, Xingpeng D1, Deyi L1

Research Type

Pure and Applied Science / Translational

Abstract Category

Pelvic Pain Syndromes

Abstract 160
Pelvic Pain
Scientific Podium Short Oral Session 18
Thursday 8th October 2026
15:22 - 15:30
Plenary Hall 1
Auditorium 1
Capacity: 1068
Animal Study Basic Science Painful Bladder Syndrome/Interstitial Cystitis (IC) Stem Cells / Tissue Engineering
1. Department of Urology, Institute of Urology, West China Hospital, Sichuan University
Presenter
Links

Abstract

Hypothesis / aims of study
Interstitial cystitis/bladder pain syndrome (IC/BPS) is characterized by urothelial barrier disruption and impaired epithelial regeneration, with limited recovery from current therapies. We hypothesized that bladder organoids (BLOs) can enhance epithelial repair in injured bladders through structural anchoring and activation of Wnt1–β-catenin signaling. This study aimed to evaluate the regenerative potential and mechanisms of proliferative and differentiated BLOs (P-BLO and D-BLO) in a preclinical bladder injury model.
Study design, materials and methods
Rat proliferative (P-BLO) and differentiated (D-BLO) bladder organoids were generated in 3D matrix gel cultures (Reference 1). In a cyclophosphamide (CYP)-induced rat bladder injury model, hyaluronic acid (HA), P-BLO, or D-BLO were instilled intravesically twice at a 48-hour interval. Bladder repair was assessed 24 hours after instillation via tissue histology, pain thresholds, and urinary spot counting. Intravesical retention of instillates was evaluated via in vivo imaging 60 minutes post-instillation. Single-cell RNA sequencing (scRNA-seq) was performed on normal, CYP-injured bladders, and organoids to dissect the cellular and molecular mechanisms underlying epithelial regeneration.
Results
P-BLO and HA instillation increased pain thresholds, reduced urinary spots, thickened the urothelium, increased the proportion of E-cadherin+ cells, and decreased IL-1β+ cells, whereas D-BLO had no significant effects. After the second instillation, P-BLO outperformed HA in pain reduction, epithelial marker restoration, and suppression of inflammation. In vivo imaging revealed superior intravesical retention of P-BLO compared with HA or D-BLO. scRNA-seq revealed that P-BLO upregulated Spp1–Itga9 and Cd44–Lama2 interactions with injured urothelium, and activated Wnt1–β-catenin signaling, counteracting CYP-induced suppression of Ctnnb1.
Interpretation of results
P-BLO promotes epithelial regeneration and repair via dual anchoring structures (Spp1–Itga9 and Cd44–Lama2) and reactivation of Wnt1–β-catenin signaling. Superior retention and functional integration of P-BLO relative to HA contribute to enhanced epithelial restoration and pain alleviation.
Concluding message
Proliferative bladder organoids provide a reproducible and controllable platform for epithelial repair in IC/BPS, offering a potential therapeutic strategy that combines mechanical anchoring and molecular pathway activation for targeted urothelial regeneration.
References
  1. Santos CP, Lapi E, Martínez de Villarreal J, Álvaro-Espinosa L, Fernández-Barral A, Barbáchano A, Domínguez O, Laughney AM, Megías D, Muñoz A, Real FX. Urothelial organoids originating from Cd49fhigh mouse stem cells display Notch-dependent differentiation capacity. Nat Commun. 2019 Sep 27;10(1):4407.
Disclosures
Funding None Clinical Trial No Subjects Animal Species Rat Ethics Committee Animal Care and Use Committee of Sichuan University AI Not at all
Citation

Continence 19S (2026) 102637
DOI: 10.1016/j.cont.2026.102637

22/10/2026 05:53:10